CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 16,875	$ 12,925	$ 47,488	$ 34,836
General and administrative	7,226	5,677	21,205	15,876
Total operating expenses	24,101	18,602	68,693	50,712
Loss from operations	(24,101)	(18,602)	(68,693)	(50,712)
Other income:
Interest income	313	48	509	65
Total other income	313	48	509	65
Net loss	(23,788)	(18,554)	(68,184)	(50,647)
Cumulative dividends on redeemable convertible preferred stock				(1,228)
Net loss attributable to common stockholders	$ (23,788)	$ (18,554)	$ (68,184)	$ (51,875)
Net loss per share attributable to common stockholders, basic	$ (0.63)	$ (0.50)	$ (1.81)	$ (1.62)
Net loss per share attributable to common stockholders, diluted	$ (0.63)	$ (0.50)	$ (1.81)	$ (1.62)
Weighted Average Number of Shares Outstanding, Basic	38,009,022	36,934,311	37,582,463	32,067,535
Weighted Average Number of Shares Outstanding, Diluted	38,009,022	36,934,311	37,582,463	32,067,535
Other comprehensive loss:
Unrealized gain (loss) on available for sale investments	$ 148		$ (1,178)
Total other comprehensive loss	148		(1,178)
Comprehensive loss attributable to common stockholders	$ (23,640)	$ (18,554)	$ (69,362)	$ (51,875)